Table 3 The relationship (%) between DDD of typical and atypical antipsychotics covered by Israel’s national health care system, 2004 – 2013 (defined daily dose per 1000 psychiatric inpatients per day)
From: Trends in the use of antipsychotics in the Israeli inpatient population, 2004–2013
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Typicals DDD total | 148.62 | 132.39 | 131.27 | 136.38 | 138.11 | 138.99 | 134.64 | 148.89 | 128.81 | 125.57 |
Percent | 53.7 | 51.2 | 43.5 | 47.6 | 48.5 | 43.9 | 48.1 | 45.9 | 34.0 | 36.2 |
Atypicals DDD total | 128.1 | 126.4 | 170.8 | 149.9 | 146.8 | 177.7 | 145.4 | 175.5 | 250.3 | 221.7 |
Percent | 46.3 | 48.8 | 56.5 | 52.4 | 51.5 | 56.1 | 51.9 | 54.1 | 66.0 | 63.8 |
All | 276.72 | 258.79 | 302.07 | 286.28 | 284.91 | 316.69 | 280.04 | 324.39 | 379.11 | 347.27 |